Pharma Stalls U.S., Korean Free Trade Talks
U.S. and Korean negotiators are struggling to bridge their differences in talks to amend South Korea's regulatory regime for patented drugs, according to sources close to the negotiations....To view the full article, register now.
Already a subscriber? Click here to view full article